Pharmaffiliates Announces Successful First-Time Synthesis of Multiple Novel Impurity Standards


Posted September 12, 2025 by pharmaffiliatespvt

Pharmaffiliates announces the first-time synthesis of multiple rare impurity standards, expanding its 100,000+ compound portfolio. With 24+ years of expertise, the company continues to support global pharma R&D with quality reference standards.

 
Panchkula, India – Pharmaffiliates Private Limited, a global leader in pharmaceutical reference standards and CRDMO services, proudly announces the successful first-time synthesis of a series of rare and complex impurity standards. This milestone further strengthens Pharmaffiliates’ position as a trusted partner to the pharmaceutical industry worldwide.

The newly synthesized products expand Pharmaffiliates’ ever-growing portfolio of 100,000+ pharmaceutical and non-pharmaceutical research compounds, serving the needs of R&D organizations, manufacturers, and quality control laboratories across 100+ countries.

Key First-Time Synthesized Products Include:

3-(5-(2-Hydroxyphenyl)-1,2,4-oxadiazol-3-yl)benzoic Acid (PA 01 3741001) : https://www.pharmaffiliates.com/en/3-5-2-hydroxyphenyl-1-2-4-oxadiazol-3-yl-benzoic-acid-pa013741001.html

Chenodeoxycholic Acid - Impurity I (EP/BP) (PA 03 0370090): https://www.pharmaffiliates.com/en/chenodeoxycholic-acid-impurity-i-pa030370090.html

N-Nitroso Clozapine (PA 03 0721004) : https://www.pharmaffiliates.com/en/156632-03-0-n-nitroso-clozapine-pa030721004.html

Ciprofloxacin Hydrochloride - Impurity F (EP/BP) (PA 03 0560062) : https://www.pharmaffiliates.com/en/226903-07-7-ciprofloxacin-hydrochloride-impurity-f-pa0356060.html

Clobetasol Propionate - Impurity C (EP/BP) (PA 03 96030) :
https://www.pharmaffiliates.com/en/25122-52-5-clobetasol-propionate-impurity-c-pa0396030.html

Daunorubicin - Impurity A (EP/BP) (PA 04 08010)

Diosmin - Impurity E (EP/BP) (PA 04 70050)

Dutasteride - Impurity E (EP/BP) (PA 04 86050)

Dapagliflozin ?-Isomer (PA 04 93560)

Eplerenone 6-?-Hydroxy Analog (PA 05 49510)

Gliclazide - Impurity E (EP/BP) (PA 07 08050)

Iodixanol - Impurity F (EP/BP) (PA 09 52060)

Loperamide - Impurity G (EP/BP) (PA 12 24070)

Methylprednisolone - Impurity B (EP/BP) (PA 13 32020)

Naloxone Hydrochloride - Impurity G (EP/BP) (PA 14 06070)

Prochlorperazine Maleate - Impurities A & C (EP/BP) (PA 16 71510, PA 16 71520)

Spironolactone Epimer Mixture (PA 19 18530)

Tacrolimus Hydroxy Acid Impurity (PA 20 01600)

Triamcinolone Acetonide - Impurity B (EP/BP) (PA 20 49020)

Calcipotriol - Impurity A (EP/BP) (PA 30 16010)

Fluticasone Furoate - Impurity F (EP/BP) (PA 33 0300060)

N-Nitrosopropranolol (PA 69 0301007)

Etoposide Resolution Mixture (PA 05 0701004)
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse Content Requests
Contact Email [email protected]
Issued By Pharmaffiliates Private Limited
Phone 09216959588
Business Address 225, Phase II, Panchkula
Panchkula, Haryana
Country India
Categories Manufacturing , Research
Tags crdmo , crm , hplc column , custom synthesis
Last Updated September 12, 2025